Bioactive Milk Peptides and Blood Pressure

Phase 3

Completed

• Conditions: Stage 1 Hypertension
• Interventions: Other: Placebo; Dietary Supplement: Milk peptides and plant sterols

• Registration Number: NCT01031485
• Lead Sponsor: Valio Ltd

Brief Summary

The purpose of this study is to investigate the effects of bioactive milk peptides on blood pressure in mildly hypertensive subjects.

Detailed Description

Not available

Study Timeline

• Status Verified: 2009-12
• Study First Submitted: 2009-12-11
• Study First Submitted QC: 2009-12-11
• Study First Posted: 2009-12-14
• Study Start: 2010-01
• Primary Completion: 2010-06
• Study Completion: 2010-08
• Last Update Submitted: 2014-12-19
• Last Update Posted: 2014-12-23

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• age 30-60 years
• systolic blood pressure 140-160 mmHg and diastolic blood pressure 90-99 mmHg in office measurement
• apparently healthy

Exclusion Criteria

• antihypertensive and lipid-lowering drugs
• unstable coronary artery disease, diabetes, malignant diseases, secondary hypertension
• BMI > 32 kg/m2
• milk allergy
• smoking
• alcohol abuse
• pregnancy, lactation
• simultaneous participation in other clinical trial

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Standard spread	Placebo	-
Spread with milk peptides and plant sterols	Milk peptides and plant sterols	-

Primary Outcome Measures

Name	Time	Method
Blood pressure

Trial Locations

Locations (1)

Valio Ltd; 🇫🇮 Helsinki, Uusimaa, Finland